I have been studying different cancer samples and comparing them with the germline controls for driver mutations. As a result I have found quite of few somatic mutations that are exclusive to tumour samples. However, I have also found some mutations that are present in controls, but not in any of the tumour samples. Can someone please put some light on the reason behind this?
Question: Why are there too many mutations in controls, but not in tumour?
4.3 years ago by
MAPK • 1.5k
MAPK • 1.5k wrote:
ADD COMMENT • link •
Please log in to add an answer.
Powered by Biostar version 2.3.0
Traffic: 1984 users visited in the last hour